resTORbio
About:
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Website: https://www.restorbio.com
Twitter/X: twitteer_d
Top Investors: OrbiMed, Fidelity, PureTech Health, Rock Springs Capital, Recharge Capital
Description:
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
$115M
$1M to $10M
Boston, Massachusetts, United States
2016-01-01
Remoo2123(AT)hotmail.com
Chen Schor, Joan Mannick
1-10
2019-03-22
Public
© 2025 bioDAO.ai